v3.25.3
Segment Disclosure - Summary of Significant Expenses Related to The Life Science Segment (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Revenues     $ 2,820 $ 16,146
Costs and operating expenses        
Cost of revenues       475
Research and development        
Total research and development expenses $ 17,808 $ 17,741 51,985 44,723
General and administrative        
Total general and administrative expenses 5,653 6,013 16,960 20,339
Total costs and operating expenses 23,461 23,754 68,945 65,537
Other segment income 1,458 2,551 4,893 7,631
Income tax expense     283  
Net loss (22,003) (21,203) (61,515) (41,760)
Reconciliation of profit or loss        
Consolidated net loss (22,003) (21,203) (61,515) (41,760)
Operating Segments        
Costs and operating expenses        
Cost of revenues 0 0 0 475
Research and development        
Total research and development expenses 17,808 17,741 51,985 44,723
General and administrative        
Total general and administrative expenses 5,653 6,013 16,960 20,339
Total costs and operating expenses 23,461 23,754 68,945 65,537
Other segment income 1,458 2,551 4,893 7,631
Income tax expense     283  
Net loss (22,003) (21,203) (61,515) (41,760)
Milestone revenue, royalty revenue and sale of royalty rights | Operating Segments        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Revenues 0 0 2,820 16,146
Clinical product candidates | Operating Segments        
Research and development        
Total research and development expenses 6,727 6,888 16,261 14,648
Clinical product manufacturing | Operating Segments        
Research and development        
Total research and development expenses 4,582 4,267 14,160 10,487
Personnel-related expenses excluding stock-based compensation | Operating Segments        
Research and development        
Total research and development expenses 3,738 3,663 11,967 10,649
General and administrative        
Total general and administrative expenses 1,519 1,245 4,070 4,399
Stock-based compensation        
Research and development        
Total research and development expenses 698 836 2,389 2,285
General and administrative        
Total general and administrative expenses 2,375 2,145 7,330 7,887
Depreciation and amortization        
Research and development        
Total research and development expenses 454 131 1,385 670
Professional and consultant fees | Operating Segments        
General and administrative        
Total general and administrative expenses 713 1,024 2,390 3,238
Other | Operating Segments        
Research and development        
Total research and development expenses 1,609 1,956 5,823 5,984
General and administrative        
Total general and administrative expenses $ 1,046 $ 1,599 $ 3,170 $ 4,815